These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31404062)

  • 1. Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
    Stangou M; Marinaki S; Papachristou E; Kolovou K; Sambani E; Zerbala S; Papadea P; Balafa O; Rapsomanikis KP; Andrikos A; Manolakaki P; Papadopoulou D; Mitsopoulos E; Liakou H; Andronikidi PE; Choulitoudi V; Moustakas G; Galitsiou D; Dafnis E; Stylianou K; Stefanidis I; Golfinopoulos S; Panagoutsos S; Tsilivigkou M; Papadogianakis A; Tzanakis I; Sioulis A; Vlachakos D; Grapsa E; Spaia S; Kaperonis N; Paliouras C; Dioudis C; Papoulidou F; Apostolou T; Iatrou C; Boletis I; Goumenos D; Papagianni A
    PLoS One; 2019; 14(8):e0217116. PubMed ID: 31404062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China.
    He HG; Huang YY; Liang QQ; Ye QR; Li AD; Ye K; Wu QX; You YW
    Ren Fail; 2023; 45(2):2253930. PubMed ID: 37724535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
    Qiu TT; Zhang C; Zhao HW; Zhou JW
    Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
    Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
    Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the efficacy of different treatments for idiopathic membranous nephropathy: a retrospectively real-world study.
    Sun M; Huang J; Dong J; Li Z; Li C; Zhang S; Chen B
    Curr Med Res Opin; 2023 May; 39(5):761-769. PubMed ID: 36938631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region.
    Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA
    Nephrology (Carlton); 2022 Jan; 27(1):35-43. PubMed ID: 34392579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
    Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH
    J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy.
    Rojas-Rivera J; Fervenza FC; Ortiz A
    Drugs; 2022 Feb; 82(2):109-132. PubMed ID: 34932208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis.
    Li K; Yu Y; Gao Y; Gao J
    Medicine (Baltimore); 2022 Feb; 101(8):e28891. PubMed ID: 35212292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic Reticulum Stress Predicts Clinical Response to Cyclosporine Treatment in Primary Membranous Nephropathy.
    Tao J; Zhang W; Wen Y; Sun Y; Chen L; Li H; Li M; Li X; Lafayette RA; Li X
    Am J Nephrol; 2016; 43(5):348-56. PubMed ID: 27166157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC
    J Nephrol; 2022 May; 35(4):1159-1170. PubMed ID: 35199314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
    Ramachandran R; Kumar V; Jha V
    Kidney Int; 2016 Jun; 89(6):1401-2. PubMed ID: 27181781
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis.
    Zhu LB; Liu LL; Yao L; Wang LN
    Drugs; 2017 Feb; 77(2):187-199. PubMed ID: 28084563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.